KURA Company Profile and Key Details

Q: Who are the executives of KURA?

Ms. Kirsten FlowersChief Commercial Officer & Chief Corporation Strategy OfficerMr. Pete De SpainSenior Vice President of Investor Relations & Corporation CommunicationsDr. Stephen Dale M.D.Chief Medical OfficerMs. Kathleen FordChief Operating OfficerMr. Thomas DoyleSenior Vice President of Fin. & AccountingDr. Roger Bakale Ph.D.Vice President and Head of CMC, Clinical & Commercial ManufacturingMr. James E. Basta J.D., Esq.Chief Compliance Officer & Corporation Sec.Ms. Teresa Brophy Bair Esq., J.D.Chief Legal Officer & Corporation Sec.Ms. Maureen Clancy M.B.A.Vice President and Global Head of Program Leadership & Project ManagementDr. Troy Edward Wilson J.D., Ph.D.Co-Founder & Chairman

NASDAQ : KURA

Kura Oncology

$8.68

-0.13-1.48%

At Close 4:00 PM

58.08

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Kura Oncology, Inc. (KURA) stock declined over -1.48%, trading at $8.68 on NASDAQ, down from the previous close of $8.81. The stock opened at $8.90, fluctuating between $8.67 and $9.15 in the recent session.

Stock Snapshot

8.81

Prev. Close

770.56M

Market Cap

8.67

Day Low

-2.59

P/E Ratio

-3.35

EPS (TTM)

-1.62

Cash Flow per Share

8.9

Open

88.77M

Number of Shares

9.15

Day High

96.92%

Free Float in %

5.14

Book Value

1.54M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 10, 2026	8.91	9.15	8.67	8.68	1.82M
Jun 09, 2026	8.78	9.02	8.62	8.81	2.01M
Jun 08, 2026	8.88	8.94	8.39	8.56	1.43M
Jun 05, 2026	8.76	9.21	8.56	8.74	3.23M
Jun 04, 2026	8.75	9.05	8.64	8.77	2.09M
Jun 03, 2026	8.95	8.96	8.63	8.65	1.57M
Jun 01, 2026	10.17	10.17	9.03	9.04	2.09M
May 29, 2026	9.97	10.35	9.90	10.20	1.72M
May 28, 2026	10.13	10.18	9.89	9.97	1.6M
May 27, 2026	10.41	10.56	10.23	10.24	1.45M
May 26, 2026	11.34	11.43	10.39	10.41	2.93M
May 22, 2026	11.12	11.52	11.01	11.25	2.49M
May 21, 2026	10.20	11.46	10.18	11.13	5.23M
May 20, 2026	8.98	10.38	8.98	10.34	5.34M
May 19, 2026	9.21	9.23	8.95	8.96	1.4M
May 18, 2026	9.22	9.51	9.04	9.20	1.12M
May 15, 2026	9.66	9.79	9.17	9.22	1.52M
May 14, 2026	9.61	9.99	9.55	9.74	2.02M
May 13, 2026	8.97	9.54	8.76	9.48	2.43M
May 12, 2026	9.52	9.94	9.38	9.68	1.83M

Contact Details

San Diego, CA 92130

United States

https://kuraoncology.com 858 500 8800

About Company

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.

Stock Peers

ARGX

-21.82-2.47%

argenx SE$862.18 REGN

-14.53-2.36%

Regeneron Pharmaceuticals, Inc.$601.65 UTHR

-9.04-1.63%

United Therapeutics Corporation$544.10 MDGL

-5.57-1.17%

Madrigal Pharmaceuticals, Inc.$471.32 VRTX

-10.06-2.26%

Vertex Pharmaceuticals Incorporated$435.71 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

2.66+0.86%

Krystal Biotech, Inc.$312.41 ALNY

-6.47-2.17%

Alnylam Pharmaceuticals, Inc.$291.22 LGND

4.96+2.04%

Ligand Pharmaceuticals Incorporated$248.24 AXSM

0.7+0.28%

Axsome Therapeutics, Inc.$246.34

Frequently Asked Questions

What is the current Kura Oncology, Inc. (KURA) stock price?

Kura Oncology, Inc. (NASDAQ: KURA) stock price is $8.68 in the last trading session. During the trading session, KURA stock reached the peak price of $9.15 while $8.67 was the lowest point it dropped to. The percentage change in KURA stock occurred in the recent session was -1.48% while the dollar amount for the price change in KURA stock was - $0.13.

KURA's industry and sector of operation?

The NASDAQ listed KURA is part of Biotechnology industry that operates in the broader Healthcare sector. Kura Oncology, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of KURA?

Ms. Kirsten Flowers
Chief Commercial Officer & Chief Corporation Strategy Officer
Mr. Pete De Spain
Senior Vice President of Investor Relations & Corporation Communications
Dr. Stephen Dale M.D.
Chief Medical Officer
Ms. Kathleen Ford
Chief Operating Officer
Mr. Thomas Doyle
Senior Vice President of Fin. & Accounting
Dr. Roger Bakale Ph.D.
Vice President and Head of CMC, Clinical & Commercial Manufacturing
Mr. James E. Basta J.D., Esq.
Chief Compliance Officer & Corporation Sec.
Ms. Teresa Brophy Bair Esq., J.D.
Chief Legal Officer & Corporation Sec.
Ms. Maureen Clancy M.B.A.
Vice President and Global Head of Program Leadership & Project Management
Dr. Troy Edward Wilson J.D., Ph.D.
Co-Founder & Chairman

How KURA did perform over past 52-week?

KURA's closing price is 59.27% higher than its 52-week low of $5.45 where as its distance from 52-week high of $12.49 is -30.5%.

How many employees does KURA have?

Number of KURA employees currently stands at 192.

Link for KURA official website?

Official Website of KURA is: https://kuraoncology.com

How do I contact KURA?

KURA could be contacted at phone 858 500 8800 and can also be accessed through its website. KURA operates from 12730 High Bluff Drive, San Diego, CA 92130, United States.

How many shares of KURA are traded daily?

KURA stock volume for the day was 1.54M shares. The average number of KURA shares traded daily for last 3 months was 1.63M.

What is the market cap of KURA currently?

The market value of KURA currently stands at $770.56M with its latest stock price at $8.68 and 88.77M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	192
Beta	0.24
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	192
Beta	0.24
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

KURA Company Profile and Key Details

Kura Oncology

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways